- Home
- GHRS vs XPOF Comparison
GHRS vs XPOF Comparison
Compare GHRS & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- XPOF
- Stock Information
- Founded
- GHRS 2018
- XPOF 2017
- Country
- GHRS Ireland
- XPOF United States
- Employees
- GHRS N/A
- XPOF N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- XPOF Services-Misc. Amusement & Recreation
- Sector
- GHRS Health Care
- XPOF Consumer Discretionary
- Exchange
- GHRS Nasdaq
- XPOF Nasdaq
- Market Cap
- GHRS 849.8M
- XPOF 295.1M
- IPO Year
- GHRS 2021
- XPOF 2021
- Fundamental
- Price
- GHRS $12.06
- XPOF $7.54
- Analyst Decision
- GHRS Strong Buy
- XPOF Buy
- Analyst Count
- GHRS 8
- XPOF 9
- Target Price
- GHRS $30.63
- XPOF $13.94
- AVG Volume (30 Days)
- GHRS 176.0K
- XPOF 462.7K
- Earning Date
- GHRS 05-08-2025
- XPOF 07-31-2025
- Dividend Yield
- GHRS N/A
- XPOF N/A
- EPS Growth
- GHRS N/A
- XPOF N/A
- EPS
- GHRS N/A
- XPOF N/A
- Revenue
- GHRS N/A
- XPOF $317,536,000.00
- Revenue This Year
- GHRS N/A
- XPOF $1.62
- Revenue Next Year
- GHRS N/A
- XPOF $6.11
- P/E Ratio
- GHRS N/A
- XPOF N/A
- Revenue Growth
- GHRS N/A
- XPOF N/A
- 52 Week Low
- GHRS $6.00
- XPOF $6.64
- 52 Week High
- GHRS $20.50
- XPOF $18.95
- Technical
- Relative Strength Index (RSI)
- GHRS 52.59
- XPOF 37.59
- Support Level
- GHRS $11.50
- XPOF $7.54
- Resistance Level
- GHRS $12.94
- XPOF $8.22
- Average True Range (ATR)
- GHRS 0.98
- XPOF 0.41
- MACD
- GHRS -0.14
- XPOF -0.12
- Stochastic Oscillator
- GHRS 32.73
- XPOF 5.99
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.